Spastic Paraplegia Epilepsy Mental Retardation News - LARVOL Sigma

Spastic Paraplegia Epilepsy Mental Retardation

Welcome, Profile Billing Logout

17 Mechanisms of Action

|||||||||| New P4 trial: Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak (clinicaltrials.gov) - Jun 14, 2012
P4, N=435, Completed, Sponsor: Universitair Ziekenhuis Brussel

||||||||||  Androxal (enclomifene) / AbbVie
P3 data, Trial initiation date:  Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism (clinicaltrials.gov) -  Jun 11, 2012
P3, N=151, Completed,  Sponsor: Repros Therapeutics Inc.
Initiation date: May 2012 --> Aug 2012

|||||||||| Trial completion: Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm (clinicaltrials.gov) - Jun 6, 2012
P=N/A, N=84, Completed, Sponsor: University of South Florida
Initiation date: May 2012 --> Aug 2012 Recruiting --> Completed

|||||||||| Biomarker, Trial withdrawal: Molecular Markers of Human Sperm Function (clinicaltrials.gov) - May 8, 2012
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting --> Completed Not yet recruiting --> Withdrawn

|||||||||| Biomarker, Enrollment change: Molecular Markers of Human Sperm Function (clinicaltrials.gov) - May 8, 2012
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting --> Withdrawn N=356 --> 0

|||||||||| Preclinical, Enrollment change: A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Controlled Ovarian Hyperstimulation (clinicaltrials.gov) - Mar 26, 2012
P=N/A, N=356, Completed, Sponsor: Merck KGaA
N=356 --> 0 N=500 --> 356

|||||||||| Trial completion, Preclinical: A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Controlled Ovarian Hyperstimulation (clinicaltrials.gov) - Mar 26, 2012
P=N/A, N=356, Completed, Sponsor: Merck KGaA
N=500 --> 356 Active, not recruiting --> Completed

|||||||||| New P1 trial: Does Flushing the Uterine Cavity With Follicular Fluid After Ovum Pick-up Improve Implantation Rates in ICSI Cycles? (clinicaltrials.gov) - Mar 25, 2012
P1, N=100, Completed, Sponsor: Nawara Mohamed Hashish

|||||||||| New P4 trial, Preclinical: Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing In Vitro Fertilization Cycles (clinicaltrials.gov) - Mar 19, 2012
P4, N=0, Completed, Sponsor: AGUNCO Obstetrics and Gynecology Centre

|||||||||| Trial termination, Discordant: ARTEMIS: Intrauterine Insemination In HIV-Discordant Couples (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=10, Terminated, Sponsor: Boston Medical Center
Active, not recruiting --> Completed Recruiting --> Terminated; The field has changed, and we have decided to develop a PrEP program.

|||||||||| Enrollment change, Discordant: ARTEMIS: Intrauterine Insemination In HIV-Discordant Couples (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=10, Terminated, Sponsor: Boston Medical Center
Recruiting --> Terminated; The field has changed, and we have decided to develop a PrEP program. N=50 --> 10

||||||||||  Androxal (enclomifene) / AbbVie
New P3 trial, P3 data:  Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism (clinicaltrials.gov) -  Feb 12, 2012
P3, N=151, Completed,  Sponsor: Repros Therapeutics Inc.

|||||||||| Clinical data, Enrollment change: ESCORT: An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques (clinicaltrials.gov) - Jan 22, 2012
P=N/A, N=8100, Recruiting, Sponsor: Merck KGaA
N=50 --> 10 N=4000 --> 8100

|||||||||| New P3 trial: Efficacy of Low Dose hCG on Oocyte Maturity in Poor Responder Women Undergoing Intracytoplasmic Sperm Injection (clinicaltrials.gov) - Jan 4, 2012
P3, N=73, Completed, Sponsor: Royan Institute

|||||||||| Trial termination: Oocyte Cryopreservation by Slow Freezing and Vitrification (clinicaltrials.gov) - Dec 30, 2011
P2/3, N=2, Terminated, Sponsor: Reproductive Medicine Associates of New Jersey
N=4000 --> 8100 Withdrawn --> Terminated; Poor recruitment

|||||||||| Enrollment change: Oocyte Cryopreservation by Slow Freezing and Vitrification (clinicaltrials.gov) - Dec 30, 2011
P2/3, N=2, Terminated, Sponsor: Reproductive Medicine Associates of New Jersey
Withdrawn --> Terminated; Poor recruitment N=500 --> 2

|||||||||| Enrollment open: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Nov 30, 2011
P3, N=368, Recruiting, Sponsor: Assistance Publique - H
N=500 --> 2 Not yet recruiting --> Recruiting

|||||||||| Trial termination: An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=25, Terminated, Sponsor: Merck KGaA
Not yet recruiting --> Recruiting Active, not recruiting --> Terminated

|||||||||| Enrollment change: An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=25, Terminated, Sponsor: Merck KGaA
Active, not recruiting --> Terminated N=250 --> 25